Clinical Observation hysteroscopy combined with Diane-35 treatment of endometrial polyps
Zhuang Yuan;Jiang Ru;Guo Chen;Jiangxi MCH Reproductive Health Branch;
Objective To evaluate hysteroscopy combined Indah-35(cyproterone ethinyl estradiol tablets) clinical effect of endometrial polyps, in order to provide a reliable clinical evidence for clinical treatment of endometrial polyps. Methods Select146 cases of patients with intra-uterine neoplasm,underwent surgical removal under hysteroscope, pathological examination confirmed the uterus endometrial polyps, the patient consent, approved by the Ethics Committee, were randomly divided into two groups, 96 patients received routine postoperative anti-inflammatory, hemostatic support treatment; treatment group, 60 patients received oral Diane-35 three cycles. Patients were followed up for 1 year, the recovery period were compared, endometrial thickness and endometrial polyp recurrence, using c2 test and t between the test group performed the statistical analysis. Results The patients in treatment group recovery period 2 months(137.65 ± 50.89) m L, half a year(152.20 ± 64.01) m L, one year(166.01 ± 28.74)m L, endometrial thickness(5.8 ± 1.5) mm and recurrence(0 cases) than the control group, the differences were statistically significant(P0.05). Conclusion hysteroscopy combined Indah-35(cyproterone ethinyl estradiol tablets) treatment of endometrial polyps inhibit endometrial proliferation, improve patient menstruation, reduce the recurrence of its clinical effect is significant for clinical utero film polyps provide a reliable basis, it is worth promoting.